BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 24057291)

  • 1. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
    Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
    Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
    BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of irisin with metabolic syndrome components and insulin secretion and resistance in schoolchildren.
    Wu CZ; Chu NF; Chang LC; Cheng CW; Lin YF; Pei D; Fang TC; Chen JS
    Medicine (Baltimore); 2021 Feb; 100(5):e24061. PubMed ID: 33592858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin is a biomarker for metabolic syndrome in prepubertal children.
    Shim YS; Kang MJ; Yang S; Hwang IT
    Endocr J; 2018 Jan; 65(1):23-31. PubMed ID: 28904307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum irisin with metabolic syndrome in obese Chinese adults.
    Yan B; Shi X; Zhang H; Pan L; Ma Z; Liu S; Liu Y; Li X; Yang S; Li Z
    PLoS One; 2014; 9(4):e94235. PubMed ID: 24709991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
    Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
    Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
    Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
    Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.
    Sesti G; Andreozzi F; Fiorentino TV; Mannino GC; Sciacqua A; Marini MA; Perticone F
    Acta Diabetol; 2014 Oct; 51(5):705-13. PubMed ID: 24619655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
    Yamaoka-Tojo M; Tojo T; Takahira N; Matsunaga A; Aoyama N; Masuda T; Izumi T
    Cardiovasc Diabetol; 2010 May; 9():17. PubMed ID: 20470376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
    Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
    Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.
    DeBoer MD; Gurka MJ; Morrison JA; Woo JG
    Int J Obes (Lond); 2016 Sep; 40(9):1353-9. PubMed ID: 27133621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells.
    De Meneck F; Victorino de Souza L; Oliveira V; do Franco MC
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):756-764. PubMed ID: 29858156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
    Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
    Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
    Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
    Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
    Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
    Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOMA-Adiponectin Closely Associates with Cardiometabolic Risk Markers in Middle-Aged Indians with Metabolic Syndrome.
    Banerjee J; Dhas Y; Mishra N
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):449-456. PubMed ID: 32189318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
    Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
    Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.